FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Kirwan

Research Profile

Disorders

Concepts & Ideas

Occupations

Rheumatology

Activities & Behaviors

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Tessa C Sanderson; Sarah E Hewlett; Caroline Flurey; Emma Dures; Pamela Richards; John R Kirwan
The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases.
John R Kirwan
Revitalising glucocorticoids for (rheumatoid) arthritis.
John R Kirwan; Lynsey Clarke; Linda P Hunt; Mark G Perry; Rainer H Straub; David S Jessop
Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Kirwan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Tessa C Sanderson; Sarah E Hewlett; Caroline Flurey; Emma Dures; Pamela Richards; John R Kirwan
The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases.
The Journal of rheumatology 2011;38(2):191-4.
2010: John R Kirwan
Revitalising glucocorticoids for (rheumatoid) arthritis.
Clinical medicine (London, England) 2010;10(2):159-60.
2010: John R Kirwan; Lynsey Clarke; Linda P Hunt; Mark G Perry; Rainer H Straub; David S Jessop
Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis.
Annals of the New York Academy of Sciences 2010;1193():127-33.
2009: George A Wells; Tracy Li; John R Kirwan; Joan Peterson; Daniel Aletaha; Maarten Boers; Barry Bresnihan; Maxime Dougados; Leanne Idzerda; Jo Nicklin; Maria Suarez Almazor; VA Welch; Peter S Tugwell
Assessing quality of sleep in patients with rheumatoid arthritis.
The Journal of rheumatology 2009;36(9):2077-86.
2009: John R Kirwan; Stanton Newman; Peter S Tugwell; George A Wells; Sarah Hewlett; Leanne Idzera; Britta Laslo; Lyn M March; Patricia Minnock; Pam Montie; Jo Nicklin; Tamara Rader; Pam Richards; Tessa C Sanderson; Maria Suarez Almazor; Elizabeth Tanjong-Ghogomu; Erin Ueffing; VA Welch
Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9.
The Journal of rheumatology 2009;36(9):2071-6.
2009: John R Kirwan; Stanton Newman; Peter S Tugwell; George A Wells
Patient perspective on outcomes in rheumatology -- a position paper for OMERACT 9.
The Journal of rheumatology 2009;36(9):2067-70.
2009: John R Kirwan; Maarten Boers Msc
The use of glucocorticoids in preventing joint destruction: Comment on the review by Schett et al.
Arthritis and rheumatism 2009;60(4):1202-3; reply 1203-4.
2009: Eman A Hasan; David S Jessop; Lynsey L Power; Paul T Monk; John R Kirwan
Use of the dexamethasone-corticotrophin releasing hormone test to assess hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis.
International journal of endocrinology 2009;2009():391284.
2007: C R Davis; J Karl; Raquel Granell; John R Kirwan; J Fasham; J Johansen; P Garnero; Mohammed Sharif
Can biochemical markers serve as surrogates for imaging in knee osteoarthritis?
Arthritis and rheumatism 2007;56(12):4038-47.
2007: John R Kirwan; Patricia Minnock; Ade Adebajo; Barry Bresnihan; Ernest H S Choy; Maarten de Wit; Mieke Hazes; Pam Richards; Kenneth G Saag; Maria Suarez Almazor; George Wells; Sarah Hewlett
Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.
The Journal of rheumatology 2007;34(5):1174-7.
2007: John R Kirwan; Sarah Hewlett
Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis.
The Journal of rheumatology 2007;34(5):1171-3.
2007: Sarah Hewlett; Maggie Hehir; John R Kirwan
Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use.
Arthritis and rheumatism 2007;57(3):429-39.
2006: John R Kirwan; Sarah H Hickey; Roger Hällgren; Herman Mielants; Ewa Björck; Tore Persson; Frank A Wollheim
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis.
Arthritis and rheumatism 2006;54(5):1415-21.
2006: Mohammed Sharif; Raquel Granell; J Johansen; Shane Clarke; C Elson; John R Kirwan
Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee.
Rheumatology (Oxford, England) 2006;45(5):522-6.
2006: Oonagh Wilson; John R Kirwan
Measuring sensation in the feet of patients with rheumatoid arthritis.
Musculoskeletal care 2006;4(1):12-23.
2006: Béla Szebenyi; Anthony P Hollander; Paul Dieppe; Brian Quilty; John Duddy; Shane Clarke; John R Kirwan
Associations between pain, function, and radiographic features in osteoarthritis of the knee.
Arthritis and rheumatism 2006;54(1):230-5.
2005: John R Kirwan; Sarah E Hewlett; Turid Heiberg; Rod A Hughes; Maggie Carr; Maggie Hehir; Tore K Kvien; Patricia Minnock; Stanton P Newman; Enid M Quest; Erik Taal; Janney Wale
Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.
The Journal of rheumatology 2005;32(11):2250-6.
2005: John R Kirwan; Monica Ahlmén; Maarten de Wit; Turid Heiberg; Maggie Hehir; Sarah Hewlett; Patricia P Katz; Patricia Minnock; Enid M Quest; Pam Richards
Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment.
The Journal of rheumatology 2005;32(11):2246-9.
2005: Marissa Lassere; Kent R Johnson; Maarten Boers; Kerri Carlton; Richard O Day; Marten de Wit; I Ralph Edwards; James F Fries; Daniel E Furst; John R Kirwan; Peter Tugwell; Thasia G Woodworth; Peter M Brooks
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
The Journal of rheumatology 2005;32(10):2037-41.
2005: Marissa Lassere; Kent R Johnson; Susanne Van Santen; Kerri Carlton; Joy Rappo; Rachel Michael; John R Kirwan; John P Edmonds
Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
The Journal of rheumatology 2005;32(10):2033-6.
2005: Marissa Lassere; Kent R Johnson; Thasia G Woodworth; Daniel E Furst; James F Fries; John R Kirwan; Peter Tugwell; Richard O Day; Peter M Brooks
Challenges and progress in adverse event ascertainment and reporting in clinical trials.
The Journal of rheumatology 2005;32(10):2030-2.
2005: George A Wells; Maarten Boers; Beverley Shea; Peter M Brooks; Lee S Simon; C Vibeke Strand; Daniel Aletaha; Jennifer J Anderson; Claire Bombardier; Maxime Dougados; Paul Emery; JIMMY MOLYNEUX; Jaap Fransen; Dan E Furst; J M W Hazes; Kent R Johnson; John R Kirwan; Robert B M Landewé; Marissa Lassere; Kaleb Michaud; Maria Suarez Almazor; Alan J Silman; Josef S Smolen; Desiree M F M Van der Heijde; P L C M van Riel; Fred Wolfe; Peter Tugwell
Minimal disease activity for rheumatoid arthritis: a preliminary definition.
The Journal of rheumatology 2005;32(10):2016-24.
2005: John Duddy; John R Kirwan; Béla Szebenyi; Shane Clarke; Raquel Granell; S Volkov
A comparison of the semiflexed (MTP) view with the standing extended view (SEV) in the radiographic assessment of knee osteoarthritis in a busy routine X-ray department.
Rheumatology (Oxford, England) 2005;44(3):349-51.
2005: John R Kirwan; Sarah Hewlett; Zoë Cockshott; John Barrett
Clinical and psychological outcomes of patient education in rheumatoid arthritis.
Musculoskeletal care 2005;3(1):1-16.
2005: Shane Clarke; Vanessa Lock; John Duddy; Mohammed Sharif; John H Newman; John R Kirwan
Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK).
The Knee 2005;12(1):57-62.
2004: Shane Clarke; C Wakeley; John Duddy; Mohammed Sharif; I Watt; K Ellingham; Christopher J Elson; G Nickols; John R Kirwan
Dual-energy X-ray absorptiometry applied to the assessment of tibial subchondral bone mineral density in osteoarthritis of the knee.
Skeletal radiology 2004;33(10):588-95.
2004: Mohammed Sharif; John R Kirwan; Christopher J Elson; Raquel Granell; Shane Clarke
Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Arthritis and rheumatism 2004;50(8):2479-88.
2004: Carole Langley; David Memel; John R Kirwan; Jon Pollock; Sarah Hewlett; D Gubbay; J Powell
Using the Health Assessment Questionnaire and welfare benefits advice to help people disabled through arthritis to access financial support.
Rheumatology (Oxford, England) 2004;43(7):863-8.
2004: John R Kirwan; Roger Hällgren; Herman Mielants; F Wollheim; E Bjorck; Tore Persson; C Book; S Bowman; M Byron; N Cox; M Field; L Kanerud; M Leirisalo-Repo; M Malaise; A Mohammad; R Palmer; Ingemar F Petersson; B Ringertz; P Sheldon; M Simonsson; N Snowden; Filip Van den Bosch
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis.
Annals of the rheumatic diseases 2004;63(6):688-95.
2003: John R Kirwan; Kathryn Mitchell; Sarah Hewlett; Maggie Hehir; Jon Pollock; David Memel; B Bennett
Clinical and psychological outcome from a randomized controlled trial of patient-initiated direct-access hospital follow-up for rheumatoid arthritis extended to 4 years.
Rheumatology (Oxford, England) 2003;42(3):422-6.
2002: Sarah Hewlett; A P Smith; John R Kirwan
Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ).
Annals of the rheumatic diseases 2002;61(11):986-93.
2002: David Memel; John R Kirwan; Carole Langley; Sarah Hewlett; Maggie Hehir
Prediction of successful application for disability benefits for people with arthritis using the Health Assessment Questionnaire.
Rheumatology (Oxford, England) 2002;41(1):100-2.
2001: Sarah Hewlett; A P Smith; John R Kirwan
Values for function in rheumatoid arthritis: patients, professionals, and public.
Annals of the rheumatic diseases 2001;60(10):928-33.
2001: John R Kirwan
Links between radiological change, disability, and pathology in rheumatoid arthritis.
The Journal of rheumatology 2001;28(4):881-6.
2001: John R Kirwan
Minimum clinically important difference: the crock of gold at the end of the rainbow?
The Journal of rheumatology 2001;28(2):439-44.
2000: Sarah Hewlett; Kathryn Mitchell; J Haynes; T Paine; E Korendowych; John R Kirwan
Patient-initiated hospital follow-up for rheumatoid arthritis.
Rheumatology (Oxford, England) 2000;39(9):990-7.
2000: David Memel; John R Kirwan; Deborah J Sharp; Maggie Hehir
General practitioners miss disability and anxiety as well as depression in their patients with osteoarthritis.
The British journal of general practice : the journal of the Royal College of General Practitioners 2000;50(457):645-8.
2000: Mohammed Sharif; L Shepstone; Christopher J Elson; Paul Dieppe; John R Kirwan
Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee.
Annals of the rheumatic diseases 2000;59(1):71-4.
1999: John R Kirwan
Conceptual issues in scoring radiographic progression in rheumatoid arthritis.
The Journal of rheumatology 1999;26(3):720-5.
1999: John R Kirwan; Géza P Bálint; Béla Szebenyi
Anniversary: 50 years of glucocorticoid treatment in rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(2):100-2.
1998: Géza P Bálint; John R Kirwan; Béla Szebenyi
[50 years of steroid treatment of rheumatoid arthritis (Philip Hench)].
Orvosi hetilap 1998;139(42):2521-3.
1997: John R Kirwan; E Rankin
Intra-articular therapy in osteoarthritis.
Baillière's clinical rheumatology 1997;11(4):769-94.
1997: John R Kirwan; Brian Quilty
Prognostic criteria in rheumatoid arthritis: can we predict which patients will require specific anti-rheumatoid treatment?
Clinical and experimental rheumatology 1997;15 Suppl 17():S15-25.